Breaking

Trump ally Bukele’s party amends El Salvador constitution to allow indefinite presidential re-election
China’s growing nuclear arsenal aims to break US alliances and dominate Asia, report warns
Kavanaugh cites 3 presidents in explaining Supreme Court’s ballooning emergency docket
Trump repositions 2 nuclear submarines after ‘highly provocative’ Russian comments
Trump endorses ‘MAGA warrior’ for RNC chairman after Whatley launches Senate campaign
WATCH: Trump says he is hopeful Hillary Clinton will be investigated for election fraud
Trump moves nuclear submarines weeks after praising sub’s power in Iran strikes
Recess on ice as Republicans hunker down for high-stakes nominee blitz

Business
Politics
World
Investing
Search for:

Investing

RAD receives IND approval from US FDA for Betabart (RV-01)

Share on Facebook Share on Twitter Pinterest LinkedIn Tumblr Email

Share

Share on Facebook Share on Twitter Pinterest Email

Radiopharm Theranostics (RAD:AU) has announced RAD receives IND approval from US FDA for Betabart (RV-01)

Download the PDF here.

This post appeared first on investingnews.com

0

Related Posts

Anglo American’s Losses Widen with Diamond Slump, Trade Tensions Mounting

Element79 Gold Corp Announces Execution of Definitive Agreement to Acquire Gold Mountain Project in Nevada

Zinc Price Update: H1 2025 in Review

Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free

Your name

Your email

By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.
Categories
- Business (44)
- Investing (219)
- Politics (233)
- World (59)

Disclaimer: TimeFinances.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.
Latest

Copyright © 2025 TimeFinances.com | All Rights Reserved

Top

Business
Politics
World
Investing

Type above and press Enter to search. Press Esc to cancel.